To advance her research using blood tests to track how tumours change over time, Professor Sarah-Jane Dawson has received $250K USD from The Mark Foundation for Cancer Research.
Melbourne’s Peter MacCallum Cancer Centre is joining forces with America’s Penn Medicine (University of Pennsylvania Health System), aiming to establish laboratory-clinical-research initiatives and open more clinical trials for Australian and American cancer patients.
First-time comedians drawn from Peter Mac’s community of patients, carers and staff have taken centre-stage for a one-night-only comedy show and wellbeing initiative.
People with a rare type of blood cancer often experience fatigue that is debilitating, distressing and profoundly affects their lives, new Peter Mac-led research has revealed.
Chronic lymphocytic leukaemia (CLL) patients who are refractory or resistant to treatment can be encouraged by data showing significantly longer survival without disease progression with a treatment combining venetoclax and rituximab compared to treatment with bendamustine plus rituximab.
A Peter Mac-led clinical trial has found combination PET/CT scans are better at investigating the causes of prolonged fever in blood cancer patients than conventional CT scans.
An AI-powered, virtual platform is being developed to improve care for patients living with genetic disorders, as part of a Digital Health CRC project led by Peter MacCallum Cancer Centre and Swinburne University of Technology.